高级检索
当前位置: 首页 > 详情页

Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究参与人:
研究单位: [1]Shanghai Henlius Biotech [2]The first affiliated hospital of bengbu medical college,Bengbu,Anhui,China [3]The Second Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China [4]Beijing Tongren Hospital, Capital Medical University,Beijing,China [5]Chinese PLA General Hospital,Beijing,China [6]Xuanwu Hospital, Capital Medical University,Beijing,China [7]The First Affiliated Hospital of Third Military Medical University (Southwest Hospital),Chongqing,Chongqing,China [8]The Second Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China [9]The Second Hospital of Lanzhou University,Lanzhou,Gansu,China [10]The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital ),Guangzhou,Guangdong,China [11]Zhujiang Hospital of Southern Medical University,Guangzhou,Guangdong,China [12]Jieyang People's Hospital,Jieyang,Guangdong,China [13]The First Affiliated Hospital of Guangxi Medical University,Nanjing,Guangxi,China [14]The People's Hospital of Guangxi Zhuang Autonomous Region,Nanning,Guangxi,China [15]Affiliated Hospital of Guizhou Medical University,Guiyang,Guizhou,China [16]The First People's Hospital of Zunyi,Zunyi,Guizhou,China [17]Cangzhou Central Hospital,Cangzhou,Hebei,China [18]The First Affiliated Hospital of Harbin Medical University,Ha'erbin,Heilongjiang,China [19]Luoyang Third People's Hospital,Luoyang,Henan,China [20]The First Affiliated Hospital of Xinxiang Medical College,Xinxiang,Henan,China [21]The Third Affiliated Hospital of Xinxiang Medical College,Xinxiang,Henan,China [22]Henan Eye Hospital,Zhengzhou,Henan,China [23]People's Hospital of Wuhan University (Hubei Provincial People's Hospital),Wuhan,Hubei,China [24]Tongji hospital, Tongji medical college, Huazhong University of Science and Technology,Wuhan,Hubei,China [25]Wuhan AIER Eye Hospital,Wuhan,Hubei,China [26]Wuhan Puren Hospital,Wuhan,Hubei,China [27]Yichang Central People's Hospital,Yichang,Hubei,China [28]Affiliated Eye Hospital of Nanchang University,Nanchang,Jiangxi,China [29]the First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China [30]Pingxiang People's Hospital,Pingxiang,Jiangxi,China [31]The First Hospital of Jilin University,Jilin,Jilin,China [32]Shenyang AIER Eye Hospital,Shenyang,Liaoning,China [33]Ningxia Hui Autonomous Region Peoples Hospital,Yinchuan,Ningxia,China [34]Shangdong Provincial Hospital,Jinan,Shandong,China [35]The Affiliated Hospital of Qingdao University,Qingdao,Shandong,China [36]Weifang Eye Hospital,Weifang,Shandong,China [37]Shanghai General Hospital,Shanghai,Shanghai,China,200233 [38]Shanghai Tenth People's Hospital,Shanghai,Shanghai,China [39]Shanxi Eye Hospital,Taiyuan,Shanxi,China [40]Tianjin Eye Hospital,Tianjin,China [41]Zhejiang provincial people's hospital,Hangzhou,Zhejiang,China [42]Lishui Municioal Central Hospital,Lishui,Zhejiang,China

研究目的:
this study will compare the efficacy and safety of HLX04-O administered by IVT with ranibizumab in patients with active CNV secondary to AMD.

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)